Table 2 Displays targets that significantly discriminated benign follicular adenoma (FA) from follicular variant of papillary thyroid carcinoma (FVPTC) (a) and follicular adenoma from follicular thyroid carcinoma (FTC) (b). (c) Demonstrates targets that significantly distinguished follicular adenoma from the papillary thyroid carcinoma (PTC) group (classic and follicular variants), while (d) displays the assay that showed a significant difference between papillary thyroid carcinoma and follicular thyroid carcinoma

From: A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples

Target

Two-tailed P-value

(a) P-values for FA vs FVPTC

 

MT1X

0.0015

CSNKIG2

0.0124

RAB23

<0.0001

HLA-DMA

0.0390

HLA-DQB1

0.0390

(b) P-values for FA vs FTC

 

MT1X

0.05

MT1K

0.0446

RAB23

0.0149

(c) P-values for FA vs PTC

 

CSNK1G2

0.0010

HLA-DQB1

0.0086

MT1X

<0.0001

RAB23

<0.0001

(d) P-value for FTC vs PTC

 

KRAS2

0.0382